Coverage of Jefferson Capital was started with bullish ratings by Wall Street analysts, who cited the company’s dominance in collecting low-balance consumer debts, strong returns, and expansion into ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Investing.com -- Jefferies initiated coverage of Jefferson Capital Inc with a Buy rating and a $29 price target, pointing to the company’s differentiated tech-based model, consistent financial ...

Morgan Stanley backed its bullish stance on U.S. equities on Monday, citing strong earnings momentum, and said it was ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Jefferies raises S&P 500 2025 year-end target to 5,600. Explore sector strategies, economic trends & stock valuation insights.

Starbucks Corporation (NASDAQ:SBUX) is a stock that Jim Cramer frequently discusses on his morning show. The CNBC TV host is ...

South Korean fashion retailer F&F Co said on Monday it has hired Goldman Sachs to advise on an acquisition of TaylorMade, and ...

Jefferies, Mizuho Financial Group, and Morgan Stanley have emerged as the leading mergers and acquisitions (M&A) financial ...

ICICI Bank's Q1 net interest income (NII) growth slightly surpassed expectations at 1 per cent year-on-year. This was boosted ...

The authority required insurance companies to allocate at least 2.5% of their paid-up capital to investment in open-ended investment fund certificates that invest in listed stocks ...

Reliance Industries’ share price declined 2.6% to an intra-day low of Rs 1,437 on the National Stock Exchange. The stock was ...